OPERATING SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2023

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

	December 31, 2022
	2022 Reported					Fixed	2022 Reported
	Valued at 2022				Currency		Valued at 2023
(millions)	Fixed Currency Rates		Other		Rate Change		Fixed Currency Rates
Net Sales
Global Industrial		$6,944.0		$-		($207.7)		$6,736.3
Global Institutional & Specialty		4,480.0		10.2		(75.9)		4,414.3
Global Healthcare & Life Sciences		1,570.0		-		(64.2)		1,505.8
Other		1,355.0		(10.2)		(31.5)		1,313.3
Corporate		124.1		-		(0.4)		123.7
Subtotal at fixed currency rates		14,473.1		-		(379.7)		14,093.4
Effect of foreign currency translation		(285.3)		-		379.7		94.4
Consolidated reported GAAP net sales		$14,187.8		$-		$-		$14,187.8
Operating Income
Global Industrial		$977.0		$0.8		($42.0)		$935.8
Global Institutional & Specialty		634.5		(1.6)		(11.2)		621.7
Global Healthcare & Life Sciences		205.0		(1.8)		(9.9)		193.3
Other		212.8		2.6		(5.5)		209.9
Corporate		(416.7)		-		2.3		(414.4)
Subtotal at fixed currency rates		1,612.6		-		(66.3)		1,546.3
Effect of foreign currency translation		(50.1)		-		66.3		16.2
Consolidated reported GAAP operating income		$1,562.5		$-		$-		$1,562.5

	December 31, 2021
	2021 Reported					Fixed	2021 Reported
	Valued at 2022		Segment		Currency		Valued at 2023
(millions)	Fixed Currency Rates		Change		Rate Change		Fixed Currency Rates
Net Sales
Global Industrial		$6,086.8		$-		($178.3)		$5,908.5
Global Institutional & Specialty		3,908.8		10.9		(63.0)		3,856.7
Global Healthcare & Life Sciences		1,149.6		-		(48.5)		1,101.1
Other		1,201.0		(10.9)		(27.6)		1,162.5
Corporate		137.4		-		-		137.4
Subtotal at fixed currency rates		12,483.6		-		(317.4)		12,166.2
Effect of foreign currency translation		249.5		-		317.4		566.9
Consolidated reported GAAP net sales		$12,733.1		$-		$-		$12,733.1
Operating Income
Global Industrial		$985.7		$0.4		($42.7)		$943.4
Global Institutional & Specialty		545.7		(1.4)		(7.6)		536.7
Global Healthcare & Life Sciences		152.3		(1.6)		(9.7)		141.0
Other		184.0		2.6		(5.3)		181.3
Corporate		(316.6)		-		2.3		(314.3)
Subtotal at fixed currency rates		1,551.1		-		(63.0)		1,488.1
Effect of foreign currency translation		47.5		-		63.0		110.5
Consolidated reported GAAP operating income		$1,598.6		$-		$-		$1,598.6

Schedule of financial information for each of the entity's reportable segments

	Net Sales						Operating Income (Loss)
(millions)	2023		2022		2021		2023		2022		2021
Global Industrial		$7,193.1		$6,736.3		$5,908.5		$1,080.7		$935.8		$943.4
Global Institutional & Specialty		4,994.0		4,414.3		3,856.7		823.0		621.7		536.7
Global Healthcare & Life Sciences		1,576.9		1,505.8		1,101.1		160.0		193.3		141.0
Other		1,442.3		1,313.3		1,162.5		255.0		209.9		181.3
Corporate		69.1		123.7		137.4		(331.7)		(414.4)		(314.3)
Subtotal at fixed currency		15,275.4		14,093.4		12,166.2		1,987.0		1,546.3		1,488.1
Effect of foreign currency translation		44.8		94.4		566.9		5.3		16.2		110.5
Consolidated reported GAAP		$15,320.2		$14,187.8		$12,733.1		$1,992.3		$1,562.5		$1,598.6

Schedule of net sales and long-lived assets at public exchange rates by geographic region

	Long-Lived Assets, net
(millions)	2023		2022
United States		$2,708.6		$2,508.9
Europe		631.2		574.3
Asia Pacific		213.0		210.3
Latin America		175.1		146.5
Greater China		167.4		176.6
India, Middle East and Africa		68.2		64.1
Canada		64.6		60.9
Total		$4,028.1		$3,741.6